Skip to content

The Biological Basis Research of Qi-deficiency Syndrome based on ZangFu in TCM: A systematic clinical study to explore the biological basis of chronic glomerulonephritis with Qi-deficiency syndrome

The Biological Basis Research of Qi-deficiency Syndrome based on ZangFu in TCM: A systematic clinical study to explore the biological basis of chronic glomerulonephritis with Qi-deficiency syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017507
Enrollment
Unknown
Registered
2018-08-02
Start date
2018-08-06
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic glomerulonephritis

Interventions

Patients with chronic glomerulonephritis:Qi-tonifying formula
Normal control:none

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 35-70 years old, male or female; 2. TCM diagnosis of Qi-deficiency syndrome; 3. CGN diagnostic criteria, greater than 50% of participants having kidney biopsy; 4. urinary protein excretion between 0.5 and 6g/d; 5. eGFR =30 mL/min (calculated using the Chronic Kidney Disease Epidemiology Collaboration creatinine equation), serum albumin =30g/L; 6. Controlled hypertension, blood pressure < 140/90 mmHg; 7. Volunteers participate with signed the Letter of Informed and Consent.

Exclusion criteria

Exclusion criteria: 1. Patients with secondary renal diseases (e.g., lupus nephritis, Diabetic kidney disease, hypertensive kidney lesion); 2. Those who have complicated accompanying syndromes, including excess syndromes such as phlegm, coldness, and heat toxicity, as well as patients with obvious yin deficiency or yang deficiency; 3. Patients with major systemic diseases combined such as the cardio-cerebral-vascular system, nervous system, and immune system; 4. Patients who has taken glucocorticoids, immunosuppressants or antibiotics in the past 1 month; 5. Patients with allergic constitution; 6. Women who are pregnant, lactating, or have a pregnancy intention or positive pregnancy test (test urine HCG or blood HCG), or those who cannot take effective contraception during the study (effective contraception includes sterilization, IUD, oral contraceptives or the diaphragm method by the local law); 7. Patients who participated in other drug clinical trials in the past 1 month; 8. Patients with mental disorders, neurological impediments, or failure to express themselves or communicate; 9. Alcoholics, drug abusers and addicts.

Design outcomes

Secondary

MeasureTime frame
24-hour urine protein;urinary red blood cell;serum creatinine;eGFR;

Primary

MeasureTime frame
The syndrome scorings of the Qi-deficiency;

Countries

China

Contacts

Public ContactRenhuan Yu

Xiyuan Hospital of China Academy of Chinese Medical Sciences

tezhongeyu@vip.sina.com+86 13611196162

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026